Jeff Yass’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$380K Buy
91,400
+43,700
+92% +$233K ﹤0.01% 10408
2026
Q2
$281K Sell
47,700
-217,200
-82% -$1.03M ﹤0.01% 11194
2026
Q1
$1.58M Buy
264,900
+76,600
+41% +$463K ﹤0.01% 6738
2025
Q4
$987K Buy
188,300
+93,300
+98% +$369K ﹤0.01% 7221
2025
Q3
$411K Buy
+95,000
New +$171K ﹤0.01% 9416
2025
Q1
– Sell
-12,100
Closed -$30.2K – 13604
2024
Q4
$30.2K Sell
12,100
-113,400
-90% -$404K ﹤0.01% 11836
2024
Q3
$510K Buy
+125,500
New +$469K ﹤0.01% 8422

Other funds holding ZURA

Jeff Yass's ZURA Position: Q3 2026 in Review

Jeff Yass opened a new position in Zura Bio (ZURA) in Q3 2026: 15,154 shares worth $63K. The stake represents ﹤0.01% of the portfolio and ranks #12794 among its holdings. This is a return to the name: Jeff Yass previously reported a position in ZURA as recently as Q1 2026.

Jeff Yass first reported a position in ZURA in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.49M in Q4 2025. 122 funds tracked by Wall St. Rank hold ZURA as of Q3 2026.

  • Jeff Yass held 15,154 shares of Zura Bio worth $63K as of Q3 2026.
  • Zura Bio was a new Jeff Yass position in Q3 2026.
  • Zura Bio made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12794 holding.
  • Jeff Yass first reported a position in Zura Bio in Q4 2023 and has held it in 9 quarters since.
  • Jeff Yass's Zura Bio position peaked at $1.49M in Q4 2025.
  • 122 funds tracked by Wall St. Rank held Zura Bio as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.